Cytokine gene variants and treatment outcome of cisplatin-based concomitant chemoradiotherapy in cervical cancer

References

• Ferlay J, Ervik M, Lam F, et al. Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer. [cited 2019 May 23]. Available from: https://gco.iarc.fr/today
   Google Scholar
• Sreedevi A, ssJaved R, Dinesh A. Epidemiology of cervical cancer with special focus on India. Int J Womens Health. 2015;7:405–414.
   PubMed Web of Science ®Google Scholar
• Gupta MK, Singh R, Banerjee M. Cytokine gene polymorphisms and their association with cervical cancer: a North Indian study. Egypt J Med Hum Genet. 2016;17:155–163.
   Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2014;144:646–674.
   Google Scholar
• Grabowska AK, Riemer AB. Suppl 2: the invisible enemy–how human papillomaviruses avoid recognition and clearance by the host immune system. Open Virol J. 2012;6:249.
   PubMedGoogle Scholar
• Peghini BC, Abdalla DR, Barcelos AC, et al. Local cytokine profiles of patients with cervical intraepithelial and invasive neoplasia. Hum Immunol. 2012;73:920–926.
   PubMed Web of Science ®Google Scholar
• Jebreel A, Mistry D, Loke D, et al. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer. J Laryngol Otol. 2007;121:246–252.
   PubMed Web of Science ®Google Scholar
• Torres-Poveda K, Bahena-Román M, Madrid-González C, et al. Role of IL-10 and TGF-β1 in local immunosuppression in HPV-associated cervical neoplasia. World J Clin Oncol. 2014;5:753.
   PubMedGoogle Scholar
• Duray A, Demoulin S, Hubert P, et al. Immune suppression in head and neck cancers: a review. Clin Dev Immunol. 2011;10:2010.
   Google Scholar
• Tjiong MY, van der Vange N, Ten Kate FJ, et al. Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer. Gynecol Oncol. 1999;73:285–291.
   PubMed Web of Science ®Google Scholar
• Iglesias M, Plowman GD, Woodworth CD. Interleukin-6 and interleukin-6 soluble receptor regulate proliferation of normal, human papillomavirus-immortalized, and carcinoma-derived cervical cells in vitro. Am J Pathol. 1995;146:944.
   PubMed Web of Science ®Google Scholar
• Scott M, Nakagawa M, Moscicki AB. Cell-mediated immune response to human papillomavirus infection. Clin Diagn Lab Immunol. 2001;8:209–220.
   PubMedGoogle Scholar
• Powell CB, Scott JH, Collins JL. Characterization of the protein synthesis independent TNFα lytic mechanism in human ovarian and cervical carcinoma cell lines. Gynecol Oncol. 1996;62:42–48.
   PubMed Web of Science ®Google Scholar
• March ME, Sleiman PM, Hakonarson H. Genetic polymorphisms and associated susceptibility to asthma. Int J Gen Med. 2013;6:253.
   PubMedGoogle Scholar
• Xu Y, Teng F, Huang S, et al. Changes of saliva microbiota in nasopharyngeal carcinoma patients under chemoradiation therapy. Arch Oral Biol. 2014;59:176–186.
   PubMed Web of Science ®Google Scholar
• Abbas M, Kushwaha VS, Srivastava K, et al. Impact of GSTM1, GSTT1 and GSTP1 genes polymorphisms on clinical toxicities and response to concomitant chemoradiotherapy in cervical cancer. Br J Biomed Sci. 2018;75:169–174.
   PubMed Web of Science ®Google Scholar
• Abbas M, Kushwaha VS, Srivastava K, et al. Glutathione S-transferase gene polymorphisms and treatment outcome in cervical cancer patients under concomitant chemoradiation. PloS One. 2015;10:e0142501.
   PubMed Web of Science ®Google Scholar
• Gupta MK, Kushwah AS, Singh R, et al. Genotypic analysis of XRCC4 and susceptibility to cervical cancer. Br J Biomed Sci. 2019;15:1–6.
   Google Scholar
• Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res. 1988;16:12–15.
   Web of Science ®Google Scholar
• Lu L, Wang F, He L, et al. Interaction between IGF1 polymorphisms and the risk of acute lymphoblastic leukemia in Chinese children. Cell Physiol Biochem. 2015;36:1346–1358.
   PubMedGoogle Scholar
• El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000;404:398–402.
   PubMed Web of Science ®Google Scholar
• Johansson M, DeNardo DG, Coussens LM. Polarized immune responses differentially regulate cancer development. Immunol Rev. 2008;222:145–154.
   PubMed Web of Science ®Google Scholar
• Ruzzo A, Graziano F, Pizzagalli F, et al. Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype. Ann Onco. 2005;16:887–892.
   PubMed Web of Science ®Google Scholar
• Singh H, Sachan R, Goel H, et al. Genetic variants of interleukin‐1RN and interleukin‐1β genes and risk of cervical cancer. Br J Obstet Gynaecol. 2008;115:633–638.
   Google Scholar
• Gilbert-Diamond D, Moore JH. Analysis of gene-gene interactions. Curr Protoc Hum Genet. 2011;70:1–4.
   PubMedGoogle Scholar
• Trigo FM, Luizon MR, Dutra HS, et al. Interaction between IL-6 and TNF-α genotypes associated with bacteremia in multiple myeloma patients submitted to autologous stem cell transplantation (ASCT). Leuk Res Rep. 2014;3:76–78.
   PubMedGoogle Scholar
• Saxena M, Agrawal CG, Banerjee M. Association of Interleukin-10 (IL-10), Interleukin-6 (IL-6) and Tumour Necrosis Factor-a (TNF-a) gene polymorphisms with Type 2 diabetes mellitus in North India. Mol Biol Rep. 2013;40:6271–6279.
   PubMed Web of Science ®Google Scholar